# Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT)

> **NCT06372730** · NA · RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 665 (estimated)

## Conditions studied

- Pulmonary Embolism
- Venous Thromboembolism

## Interventions

- **OTHER:** Ventilation/Perfusion Single Photon Emission Computed Tomography (V/Q SPECT/CT)

## Key facts

- **NCT ID:** NCT06372730
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-11
- **Primary completion:** 2028-12
- **Final completion:** 2029-03
- **Target enrollment:** 665 (ESTIMATED)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06372730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06372730, "Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06372730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*